Affiliation:
1. Peoples’ Friendship University of Russia (RUDN University)
2. Moscow Pedagogical State University
3. Federal Research Centre for Epidemiology and Microbiology named after the honorary academician N. F. Gamaleya of the Ministry of Health of the Russian Federation
Abstract
Introduction. Single-domain antibodies (nanobodies) are composed of the heavy-chain variable domain only. Compared to conventional immunoglobulins G (IgG) nanobodies have such qualities as: high bioavailability, ability to bind epitopes that are difficult to reach, high solubility and thermal stability, etc. Nanobodies can be easily manufactured in microorganisms (E. coli) to significantly save on cost. Text. Goal of the paper consists of the description of structural and functional properties of nanobodies and its effective application. Conclusion. Nanobodies can be used in many fields of medicine and biotechnology such as research, diagnostics and therapy of oncology, infectious, hematological, inflammatory, autoimmune and neurological diseases. They can also be easily modified using another nanobody, molecules or radioactive mark as necessary. Nanobodies have huge potential for applications in diagnostics, therapy and medicine.
Publisher
Center of Pharmaceutical Analytics Ltd
Subject
Drug Discovery,Pharmaceutical Science
Reference47 articles.
1. Vjatchanin A. S., Tillib S. V. Modifications of the phage display procedure to increase the efficiency of selection of antigen-binding domains of specific single-chain camel antibodies. Biotechnology. 2008; 4: 22–27 (In Russ.).
2. Man’ko V. M., Devrishov D. A. Veterinary immunology. Fundamentals: Textbook. M: Publishing «Agrovet». 2011; 752 р. (In Russ.).
3. Yarilin. A. A. Immunology: Textbook. M.: GEOTAR-Media. 2010; 752 р. (In Russ.).
4. Abbady A. Q. et al. Evaluation of a nanobody phage display library constructed from a Brucella-immunised camel. Veterinaty Immunology and Immunopathology. 2011; 142: 49–56.
5. Delanote V. et al. Ablynx. 2014. Challenging and intractable targets. Poster: Characterization of Anti-Kv1.3 Nanobodies and activity in Inflammatory model systems. Available at: http://www.ablynx.com/ technology-innovation/nanobodies-competitive-features/ (accessed 20.03.18).
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献